NCT03972488 2026-01-21NETTER-2Advanced Accelerator ApplicationsPhase 3 Active not recruiting226 enrolled 14 charts
NCT01252251 2017-08-01RAD001 (Everolimus) and Pasireotide (SOM230) LAR in Patients With Advanced Uveal MelanomaMemorial Sloan Kettering Cancer CenterPhase 2 Completed14 enrolled 12 charts